Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)
Public ClinicalTrials.gov record NCT07224347. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
ASPREE-XT is a post-treatment, longitudinal observational follow-up study of ASPREE participants. Although the ASPREE trial medication was ceased, the study activity was not stopped and ASPREE participants are continuing with scheduled visits and phone calls. An observational follow-up phase (ASPREE-XT), began in January, 2018. This will enable the monitoring of possible delayed effects of aspirin treatment, primarily on cancer incidence, metastases and mortality. In addition to monitoring the incidence of malignancy within the ASPREE cohort, the opportunity will be taken to observe any other residual effects of aspirin on the endpoints being monitored in the cohort. Continuity of contact with study participants is the key to retention of the cohort for any ongoing or future studies.
Study identification
- NCT ID
- NCT07224347
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 19,114 participants
Conditions and interventions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 65 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 15, 2019 (Actual)
- Primary completion
- Apr 30, 2026 (Estimated)
- Completion
- Apr 30, 2026 (Estimated)
- Last update posted
- Nov 4, 2025
2019 – 2026
United States locations
- U.S. sites
- 22
- U.S. states
- 13
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Howard University | Washington D.C. | District of Columbia | 20060 | — |
| Morehouse School of Medicine | Atlanta | Georgia | 30310 | — |
| Emory/ Atlanta VAMC | Atlanta | Georgia | 30322 | — |
| Rush Alzheimer's Disease Center | Chicago | Illinois | 60612 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| Pennington Biomedical Research Center | Baton Rouge | Louisiana | 70808 | — |
| LSU Health Sciences- Shreveport | Shreveport | Louisiana | 71130 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Wayne State University | Detroit | Michigan | 48201 | — |
| HealthPartners Research Institute | Minneapolis | Minnesota | 55425 | — |
| Phalen Village Clinic | Saint Paul | Minnesota | 55106 | — |
| Wake Forest University Baptist Medical Center | Greensboro | North Carolina | 27408 | — |
| The Brody School of Medicine at East Carolina University | Greenville | North Carolina | 27834 | — |
| Einstein Medical Center | Philadelphia | Pennsylvania | 19141 | — |
| University of Pittsburgh Health Sciences Research Center | Pittsburgh | Pennsylvania | 15260 | — |
| Kent County Memorial Hospital | Pawtucket | Rhode Island | 02860 | — |
| University of Tennessee Health Science Center | Memphis | Tennessee | 38105 | — |
| University of Texas Southwestern Medical Center at Dallas | Dallas | Texas | 75390 | — |
| University of Texas Medical Branch | Galveston | Texas | 77555 | — |
| Regional Academic Health Center | Harlingen | Texas | 78550 | — |
| UT Health Science Center at San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07224347, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 4, 2025 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07224347 live on ClinicalTrials.gov.